KGBLY yields 4.82% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, KGBLY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KGBLY + JNJ for your $10,000?
Kingboard Laminates Holdings Limited, an investment holding company, manufactures and sells laminates in the People's Republic of China, other Asian countries, Europe, and the United States. It operates through Laminates, Properties, and Investments segments. The company offers glass epoxy laminates, paper laminates, and composite epoxy material laminates. It also provides upstream component materials, such as copper foils, glass yarns, glass fabrics, bleached kraft papers, epoxy resins, kraft papers for copper-clad laminates, polyvinyl butyral products, and specialty resins and chemicals. In addition, the company offers drilling services; invests in and rents properties; trades in copper; and provides hotel accommodation services. Its investment property portfolio comprises commercial, residential, and industrial properties. The company was founded in 1988 and is headquartered in Shatin, Hong Kong. Kingboard Laminates Holdings Limited is a subsidiary of Jamplan (BVI) Limited.
Full KGBLY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.